EricJFeldmanMD
Oncology • South San Francisco, CAHematologic Oncology
Vice President, Clinical Development, GlycoMimetics Inc.
Dr. Feldman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
611 Gateway Blvd
Suite 810
South San Francisco, CA 94080Phone+1 206-773-3568- Is this information wrong?
Education & Training
Westchester Medical CenterFellowship, Hematology and Medical Oncology, 1984 - 1986
New York Medical College (Metropolitan)Residency, Internal Medicine, 1981 - 1984- New York Medical CollegeClass of 1981
Certifications & Licensure
NY State Medical License 1983 - 2025
TX State Medical License 1991 - 1993- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Super Doctor SuperDoctors.com
Clinical Trials
- MRI Screening for Patients With Myelodysplastic Syndrome (MDS), Who Have Received Multiple Red Blood Cell Transfusions Start of enrollment: 2008 Jul 31
- Safety and Anti-Disease Activity of Oral Tosedostat (CHR-2797) in Elderly Subjects With Refractory or Relapsed AML Start of enrollment: 2009 Oct 01
- Conditioning Regimen of Bendamustine and Melphalan Followed by Transplant in Patients With Multiple Myeloma Start of enrollment: 2009 Apr 23
- Join now to see all
Publications & Presentations
PubMed
- Improving Unrelated Donor Equity: Assessing Mismatched Donor Opportunities with Real-World Data in a Minority-Predominant Cohort.M Bakri Hammami, Jhannine Alyssa Verceles, Mendel Goldfinger, Nishi Shah, R Alejandro Sica, Ioannis Mantzaris, Noah Kornblum, Marina Konopleva, Aditi Shastri, Lauren C...> ;Transplantation and Cellular Therapy. 2024 Feb 28
- Efficacy and safety of CAR-T cell therapy in minorities.Astha Thakkar, Michelly Abreu, Kith Pradhan, R Alejandro Sica, Aditi Shastri, Noah Kornblum, Nishi Shah, Ioannis Mantzaris, Kira Gritsman, Eric Feldman, Richard Elkind...> ;Bone Marrow Transplantation. 2022 Jul 1
- 36 citationsPhase 1/2 study of uproleselan added to chemotherapy in patients with relapsed or refractory acute myeloid leukemia.Daniel J. DeAngelo, Brian A. Jonas, Jane L. Liesveld, Dale L. Bixby, Anjali S. Advani, Paula Marlton, John L. Magnani, Helen M. Thackray, Eric J. Feldman, Michael O'Dw...> ;Blood. 2021 Sep 20
- Join now to see all
Abstracts/Posters
- A Double-Blind, Placebo-Controlled, Phase 3 Registration Trial to Evaluate the Efficacy of Uproleselan (GMI-1271) with Standard Salvage Chemotherapy in Patients with R...Eric J. Feldman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- High E-Selectin Ligand Expression Contributes to Chemotherapy-Resistance in Poor Risk Relapsed and Refractory (R/R) Acute Myeloid Leukemia (AML) Patients and Can be Ov...Eric J. Feldman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
Ichnos Sciences Announces Formation of Scientific Advisory Board to Inform Research and Development Strategy in Immuno-OncologyFebruary 28th, 2022- Ichnos Sciences Welcomes Eric Feldman, M.D., as New Chief Medical OfficerNovember 8th, 2021
Amphivena Announces New Key Leadership and AdvisorsSeptember 11th, 2017
Professional Memberships
- Member
- Member
Hospital Affiliations
Montefiore Medical CenterBronx, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
